Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInternational Workplace Group Regulatory News (IWG)

Share Price Information for International Workplace Group (IWG)

Share Price is delayed by 15 minutes
Get Live Data
182.60    -1.00 (-0.54%)
Bid:
183.30
Ask:
183.70
Spread: 0.40 (0.218%)
Market Cap: £1.76b
IWG Live PriceLast checked at - London Stock Exchange

Intraday International Workplace Group Share Chart

COVID-19 Update

23 Mar 2020 07:00

RNS Number : 1180H
IWG PLC
23 March 2020
 

 

COVID-19 Update - 23 March 2020

IWG plc, the global operator of leading coworking and workspace brands, today provides an update in respect of COVID-19.

On 3 March 2020 we reported strong revenue and profit growth. We ended 2019 strongly and this provided a positive start into January and February. In our 2019 results statement, we indicated that the outbreak of COVID-19 had led to a brief closure of some centres in China. All these centres are now operational. We expect there to be pressure on our global business as countrywide lockdowns are implemented in an increasing number of geographies. We continue to closely monitor the ongoing developments in relation to COVID-19 and are taking appropriate actions to reduce operational costs, limit both growth and maintenance capital expenditure and optimise cash flows.

Accordingly, in the circumstances, the Board has taken the prudent, precautionary decision not to pay the final dividend of 4.8p previously declared with the Group's 2019 full year results. Consequently, the resolution in respect of the 2019 final dividend will not be proposed at the AGM scheduled to be held on 12 May 2020. The Group's dividend policy will be kept under review.

In addition, the Board is taking the prudent decision to temporarily suspend the updated £100m share repurchase programme that was announced on 3 March 2020. To date £27.5m has been spent on this programme.

The Group's financial position remains strong, with a low level of financial leverage and substantial access to liquidity. Our net debt to EBITDA ratio (on a pre-IFRS 16 basis) as at 31 December 2019 was 0.7x. On 9 March 2020, we extended the maturity profile of the £950m Revolving Credit Facility until March 2025.

At the present time, given the evolving nature of the COVID-19 pandemic, it is too early to provide earnings guidance in relation to the remainder of the current financial year. While the implications of COVID-19 are difficult to determine, the Board is confident in the long-term structural growth drivers of the global flexible work market and IWG's strategy to maintain its leading position within it, as set out in the 3 March 2020 results presentation.

Our priority remains the health and wellbeing of our customers, partners and employees and we are continuing to ensure that we have the appropriate measures and precautions in place for their safety.

 

This announcement contains inside information.

 

For further information, please contact:

 

IWG plc Tel: + 41 (0) 41 723 2353

Mark Dixon, Chief Executive Officer

Eric Hageman, Chief Financial Officer

Wayne Gerry, Group Investor Relations Director

 

Brunswick Tel: + 44 (0) 20 7404 5959

Nick Cosgrove

Oli Sherwood

 

 

 

This trading update contains certain forward looking statements with respect to the operations of IWG plc. These statements and forecasts involve risk and uncertainty because they relate to events and depend upon circumstances that may or may not occur in the future. There are a number of factors that could cause actual results or developments to differ materially from those expressed or implied by these forward-looking statements and forecasts. Nothing in this announcement should be construed as a profit forecast.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDSEDFUEESSELD
Date   Source Headline
24th Aug 202312:00 pmRNSTR-1: Notification of major holdings
22nd Aug 202310:33 amRNSTR-1: Notification of Major Holdings
8th Aug 20237:00 amRNSH1 RESULTS ANNOUNCEMENT
3rd Aug 20239:53 amRNSTotal Voting Rights: Month End Disclosure
28th Jul 202312:26 pmRNSTR-1: Notification of Major Holdings
4th Jul 20231:06 pmRNSStandard form for notification of major holdings
3rd Jul 20237:00 amRNSTotal Voting Rights: Month End Disclosure
30th Jun 20239:11 amRNSDirector/PDMR Transaction
30th Jun 20239:10 amRNSTransaction Notification
29th Jun 20237:00 amRNSH1 2023 Pre-Close and Financing Update
5th Jun 20239:50 amRNSTotal Voting Rights: Month End Disclosure
24th May 20234:54 pmRNSDirector/PDMR Transaction
22nd May 20233:14 pmRNSDirector/PDMR Transaction
9th May 20231:55 pmRNSRESULTS OF ANNUAL GENERAL MEETING
2nd May 20239:59 amRNSTotal Voting Rights: Month End Disclosure
25th Apr 20237:00 amRNSFIRST QUARTER TRADING STATEMENT
6th Apr 20235:00 pmRNSAnnual General Meeting 2023
3rd Apr 20234:57 pmRNSTotal Voting Rights: Month End Disclosure
21st Mar 20234:23 pmRNSTR-1: Notification of Major Holdings
21st Mar 20239:00 amRNSAnnual Report and Accounts 2022
9th Mar 20231:00 pmRNSDirector/PDMR Transaction
9th Mar 20231:00 pmRNSDirector/PDMR Transaction
7th Mar 20237:00 amRNSIWG - 2022 Preliminary Results
2nd Mar 20237:01 amRNSTR-1: Notification of Major Holdings
2nd Mar 20237:00 amRNSTR-1: Notification of Major Holdings
1st Mar 20237:00 amRNSTotal Voting Rights: Month End Share Disclosure
1st Feb 20237:00 amRNSTotal Voting Rights: Month End Disclosure
3rd Jan 20237:00 amRNSTotal Voting Rights
1st Dec 20227:00 amRNSDirectorate Changes
1st Dec 20227:00 amRNSTotal Voting Rights: Month End Disclosure
10th Nov 202211:07 amRNSTR-1: Notification of major holdings
4th Nov 20222:22 pmRNSDirector/PDMR Transaction
1st Nov 202210:00 amRNSTotal Voting Rights: Month End Disclosure
1st Nov 20227:00 amRNSTHIRD QUARTER TRADING STATEMENT - 1 NOVEMBER 2022
17th Oct 20225:01 pmRNSDirector/PDMR Transaction
14th Oct 20227:00 amRNSTransaction notification
13th Oct 20229:23 amRNSStandard form for notification of major holdings
11th Oct 20221:00 pmRNSAppointment of Chief Financial Officer
3rd Oct 20227:00 amRNSTotal Voting Rights: Month End Disclosure
29th Sep 202211:40 amRNSTransaction notification
28th Sep 202210:59 amRNSTransaction notification
16th Sep 20223:00 pmRNSAGM UPDATE STATEMENT
1st Sep 20227:00 amRNSTotal Voting Rights: Month End Disclosure
24th Aug 20227:00 amRNSAppointment of Chief Financial Officer
9th Aug 20227:00 amRNSIWG INTERIM RESULTS ANNOUNCEMENT
1st Aug 20227:00 amRNSTotal Voting Rights: Month End Disclosure
1st Jul 20227:00 amRNSTotal Voting Rights: Month End Disclosure
23rd Jun 20227:00 amRNSTransaction in Own Shares
22nd Jun 20227:00 amRNSTransaction in Own Shares
21st Jun 20227:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.